Accumulated studies demonstrate that KIF18A is a genetic vulnerability of high-CIN tumors, and targeting KIF18A suppresses growth and metastasis of CIN+ tumors [11]. This evidence concerns the gene KIF18A and cervical squamous intraepithelial neoplasia.